These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2252896)

  • 1. The rate constant describing slow-onset inhibition of yeast AMP deaminase by coformycin analogues is independent of inhibitor structure.
    Merkler DJ; Brenowitz M; Schramm VL
    Biochemistry; 1990 Sep; 29(36):8358-64. PubMed ID: 2252896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic potential surfaces of the transition state for AMP deaminase and for (R)-coformycin, a transition state inhibitor.
    Kline PC; Schramm VL
    J Biol Chem; 1994 Sep; 269(35):22385-90. PubMed ID: 8071366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
    Schramm VL; Baker DC
    Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet AMP deaminase. Regulation by Mg-ATP2- and inorganic phosphate and inhibition by the transition state analog coformycin.
    Ashby B; Holmsen H
    J Biol Chem; 1983 Mar; 258(6):3668-72. PubMed ID: 6601104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin.
    Marrone TJ; Straatsma TP; Briggs JM; Wilson DK; Quiocho FA; McCammon JA
    J Med Chem; 1996 Jan; 39(1):277-84. PubMed ID: 8568817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of coformycin and 2'-deoxycoformycin, and substrate and inhibitor properties of the nucleosides and nucleotides in several enzyme systems.
    Bzowska A; Lassota P; Shugar D
    Z Naturforsch C Biosci; 1985; 40(9-10):710-4. PubMed ID: 3002059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-5'-phosphate deaminase. A novel herbicide target.
    Dancer JE; Hughes RG; Lindell SD
    Plant Physiol; 1997 May; 114(1):119-29. PubMed ID: 9159944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic mechanism of yeast adenosine 5'-monophosphate deaminase. Zinc content, substrate specificity, pH studies, and solvent isotope effects.
    Merkler DJ; Schramm VL
    Biochemistry; 1993 Jun; 32(22):5792-9. PubMed ID: 8504099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylate deaminase: potent inhibition by 2'-deoxycoformycin 5'-phosphate.
    Frieden C; Gilbert HR; Miller WH; Miller RL
    Biochem Biophys Res Commun; 1979 Nov; 91(1):278-83. PubMed ID: 518627
    [No Abstract]   [Full Text] [Related]  

  • 10. AMP deaminase inhibitors. 4. Further N3-substituted coformycin aglycon analogues: N3-alkylmalonates as ribose 5'-monophosphate mimetics.
    Bookser BC; Kasibhatla SR; Erion MD
    J Med Chem; 2000 Apr; 43(8):1519-24. PubMed ID: 10780908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biochemical properties of 8-amino-6-fluoro-9-beta-D-ribofuranosyl-9H-purine.
    Secrist JA; Bennett LL; Allan PW; Rose LM; Chang CH; Montgomery JA
    J Med Chem; 1986 Oct; 29(10):2069-74. PubMed ID: 3489838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic and regulatory site composition of yeast AMP deaminase by comparative binding and rate studies. Resolution of the cooperative mechanism.
    Merkler DJ; Schramm VL
    J Biol Chem; 1990 Mar; 265(8):4420-6. PubMed ID: 2407736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP deaminase inhibitors. 3. SAR of 3-(carboxyarylalkyl)coformycin aglycon analogues.
    Kasibhatla SR; Bookser BC; Probst G; Appleman JR; Erion MD
    J Med Chem; 2000 Apr; 43(8):1508-18. PubMed ID: 10780907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways of adenine nucleotide catabolism in primary rat muscle cultures.
    Zoref-Shani E; Shainberg A; Sperling O
    Biochim Biophys Acta; 1987 Dec; 926(3):287-95. PubMed ID: 2825800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin.
    Frick L; Wolfenden R; Smal E; Baker DC
    Biochemistry; 1986 Apr; 25(7):1616-21. PubMed ID: 3486673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of 5'-AMP deaminase and its inhibitors with the aid of a continuous fluorimetric assay with formycin-5'-phosphate as substrate.
    Bzowska A; Shugar D
    Z Naturforsch C J Biosci; 1989; 44(7-8):581-9. PubMed ID: 2775407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine catabolism in isolated rat hepatocytes. Influence of coformycin.
    Van den Berghe G; Bontemps F; Hers HG
    Biochem J; 1980 Jun; 188(3):913-20. PubMed ID: 7470045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of the first potent, selective, and cell penetrating adenosine 5'-monophosphate deaminase inhibitors.
    Bookser BC; Kasibhatla SR; Appleman JR; Erion MD
    Adv Exp Med Biol; 1998; 431():853-7. PubMed ID: 9598184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 5'-methylthio coformycins: specific inhibitors for malarial adenosine deaminase.
    Tyler PC; Taylor EA; Fröhlich RF; Schramm VL
    J Am Chem Soc; 2007 May; 129(21):6872-9. PubMed ID: 17488013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.